/Companies

BioDelivera

YC F26

San Francisco, US · Founded 2025 · 2 employees · 1 known investors

Find your way into BioDelivera

Sign up to see every warm intro you have to BioDelivera

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the BioDelivera team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

BioDelivera is developing GCV™, a drug delivery platform that targets diseased cells while leaving healthy ones intact and can carry genetic medicines, DNA, RNA, small molecules, or combinations of them. The company has shown results in tumors, muscle, and brain tissue, serving the therapeutics and genetic medicine sector.

BiotechHealthtechGene TherapyCell TherapyDrug DeliveryUnited States of AmericaAmerica / Canada

Founders & leadership· Y Combinator alumni (F26)

ITIkeda Trashi
Ikeda TrashiFounder/CEOIkeda Trashi holds a PhD in Biochemistry from UT Dallas, where their research focused on engineering GCVs for targeted in vivo delivery. They are co-founder and CEO of BioDelivera, which develops GCV technology for tissue-specific delivery of next-generation therapeutics.
OTOrikeda Trashi
Orikeda TrashiFounder/PresidentCo-founder and President of BioDelivera, which develops a programmable drug delivery platform called the Guided Chimeric Vehicle (GCV). She spent five years during her PhD researching drug delivery systems, work that formed the basis for the GCV platform.

Investors · 1

In the news

Frequently asked questions

What does BioDelivera do?
BioDelivera is developing GCV™, a drug delivery platform that targets diseased cells while leaving healthy ones intact and can carry genetic medicines, DNA, RNA, small molecules, or combinations of them. The company has shown results in tumors, muscle, and brain tissue, serving the therapeutics and genetic medicine sector.
Who are BioDelivera's investors?
BioDelivera's investors include Y Combinator.
Where is BioDelivera headquartered?
BioDelivera is headquartered in San Francisco, US.